Loading...

Annette1's Recent CancerCompass Activity

  • Annette1 has replied to a post on the message board

    Barbara, I'm afraid the trial ended a couple of years ago but the results were promising enough for the drug to be submitted for approval. I don't know the status as that is normally a long process. My suggestion is you contact Genentech, developer of the drug. The code name was APOMAB (apoptosis monoclongal antibodies). It was an infusion but it was virtually w/o side effects! Alternatively, my gyn onc feels another...

    May 10, 2014 view post
    Loading...
    Load more activity
    Loading more activity

    About Annette1

    Patient
    Ovarian Cancer

    We care about your feedback. Let us know how we can improve your CancerCompass experience.